Search results
Stop Spending Tax Dollars on NIH's Cruel Animal Experiments
Newsweek· 10 hours agoProject's (WCW) viral #BeagleGate campaign uncovered that Dr. Fauci's division of the NIH—the...
Q1 2024 Ocugen Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 hours agoFinally, OCU500 as soon advanced into Phase 1 clinical trial via the National Institute of Allergy and Infectious Diseases, NIAID sponsor trial, comparing the administration ...
House COVID origins panel accuses Fauci adviser of obstructing probe, subpoenas him for public...
New York Post· 6 days agoNone of the work is still being done in China...Morens “recklessly provided Dr. Daszak with access...
NIH official set to testify before COVID panel on ‘discrepancies’ in pandemic timeline
The Hill via Yahoo News· 5 days agoLawrence Tabak, principal deputy director of the National Institutes of Health (NIH), will testify...
Risk-Targeted Preventive TB Treatment Works, Particularly With Infection Testing
MedPage Today· 6 days agoLarge real-world analysis homes in on the best strategies in high- and low-burden settings
UT Health San Antonio to lead $11 million, NIH-funded study of a first-ever oral chlamydia vaccine
PRWeb· 5 days ago/PRNewswire-PRWeb/ -- A research team led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 19 hours agoAll three first-in-class modifier gene therapy product candidates currently in the clinic with OCU400 Phase 3 in progressOCU400 on track to meet 2026 Biologics License Application (BLA) and Market Authorization Application (MAA) approval targets
